• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Deaths Tied to 'Fake Xanax' Street Drug Are Soaring

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 5, 2024.

By Ernie Mundell HealthDay Reporter

THURSDAY, Jan. 4, 2024 -- Three twenty-somethings in Chicago took a street drug they thought was a harmless form of Xanax.

All three were found collapsed and unresponsive eight hours later by one of their mothers, who had them rushed to the hospital.

After multiple seizures, fever and heart damage, all three are thought to have recovered, but not before spending many days hospitalized.

According to a new report, the drug they actually took was an unapproved benzodiazepine sedative called bromazolam, with street names like "Fake Xanax" and "Dope."

It's increasingly being distributed illicitly online or on the street and, when mixed with fentanyl, is also fueling a rising number of deaths.

Law enforcement drug seizures in the United States involving bromazolam have soared from only a handful in 2018 to more than 2,900 by 2023, according to researchers led by Dr. Paul Ehlers, a toxicologist at Cook County Hospital in Chicago.

"In Illinois, bromazolam-involved deaths increased from 10 in 2021 to 51 in 2022," a five-fold increase in just one year, the team noted.

Bromazolam is showing up in other states, too.

“It’s a very powerful drug, and when you mix a drug like that and mix it with fentanyl and some of the other opiates, it’s just a recipe for disaster,” Hamilton County Coroner Jeff Jellison told Indiana's Fox59 News in December.

In a Facebook post, he said signs of dangerous bromazolam use can include "loss of coordination, dizziness, drowsiness, blurred vision, slurred speech, muscle relaxation, difficulty breathing, amnesia and death."

The three cases noted in the Chicago report occurred early in 2023 and, luckily, fentanyl was not involved. All three young people experienced multiple, recurrent seizures and required tubes while in the ICU to help maintain breathing. All showed evidence of heart damage caused by their experience.

Two of the patients, both males aged 25, recovered and were discharged after four days and 11 days of hospital care.

The youngest patient, a 20-year-old woman, developed a form of epilepsy and fell into a coma. After 11 days in one hospital she was transferred to another hospital, after which her history is unknown, Ehler's group said.

The report also notes that bromazolam is increasingly showing up in DUI cases, because of its sedating effect on drivers.

Ehler's team are alerting doctors, EMS crews and health officials to be on the lookout for overdoses involving bromazolam, especially when seizures and fever are present.

The report was published in the Jan. 5 issue of Morbidity and Mortality Weekly Report, a journal of the U.S. Centers for Disease Control and Prevention.

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted January 2024

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.